As of 2025-01-15, the Relative Valuation of Insmed Inc (INSM) is (99.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 68.93 USD, the upside of Insmed Inc based on Relative Valuation is -244.2%.
The range of the Relative Valuation is (91.31) - (113.63) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.4x - 24.7x | 20.0x |
| Forward P/E multiples | 18.9x - 23.5x | 21.1x |
| Fair Price | (91.31) - (113.63) | (99.40) |
| Upside | -232.5% - -264.8% | -244.2% |
| Date | P/E |
| 2025-01-10 | -13.51 |
| 2025-01-08 | -13.60 |
| 2025-01-07 | -13.68 |
| 2025-01-06 | -13.79 |
| 2025-01-03 | -14.46 |
| 2025-01-02 | -14.48 |
| 2024-12-31 | -14.29 |
| 2024-12-30 | -14.26 |
| 2024-12-27 | -14.41 |
| 2024-12-26 | -14.63 |
| 2024-12-24 | -14.60 |
| 2024-12-23 | -14.61 |
| 2024-12-20 | -14.58 |
| 2024-12-19 | -14.37 |
| 2024-12-18 | -14.49 |
| 2024-12-17 | -15.29 |
| 2024-12-16 | -15.19 |
| 2024-12-13 | -14.83 |
| 2024-12-12 | -14.91 |
| 2024-12-11 | -15.36 |
| 2024-12-10 | -15.03 |
| 2024-12-09 | -15.06 |
| 2024-12-06 | -15.61 |
| 2024-12-05 | -15.59 |
| 2024-12-04 | -15.60 |
| 2024-12-03 | -14.99 |
| 2024-12-02 | -14.99 |
| 2024-11-29 | -15.56 |
| 2024-11-27 | -15.71 |
| 2024-11-26 | -15.67 |
| 2024-11-25 | -15.34 |
| 2024-11-22 | -15.14 |
| 2024-11-21 | -15.28 |
| 2024-11-20 | -15.04 |
| 2024-11-19 | -15.26 |
| 2024-11-18 | -13.79 |
| 2024-11-15 | -13.72 |
| 2024-11-14 | -14.75 |
| 2024-11-13 | -14.61 |
| 2024-11-12 | -14.52 |
| 2024-11-11 | -14.87 |
| 2024-11-08 | -15.22 |
| 2024-11-07 | -14.84 |
| 2024-11-06 | -15.08 |
| 2024-11-05 | -14.34 |
| 2024-11-04 | -14.09 |
| 2024-11-01 | -14.14 |
| 2024-10-31 | -13.93 |
| 2024-10-30 | -14.55 |
| 2024-10-29 | -14.69 |